Objectives: Experiments in animal models have identified specific subcortical anatomic circuits, which are critically involved in the pathogenesis and control of seizure activity. However, whether such anatomic substrates also exist in human epilepsy is not known.
epilepsy 12 suggest that cortical-subcortical circuits have the potential to be harnessed for therapeutic benefit.
We performed EEG combined with simultaneous fMRI in a group of patients with focal epilepsies arising from a wide variety of cortical locations to test whether specific interictal epileptiform discharge (IED)-correlated hemodynamic changes occur within the human equivalent of the area tempestas. Furthermore, in another group of patients with extratemporal epilepsy syndromes, we used 11 C-labeled flumazenil (FMZ) PET to assess seizure-related metabolic ␥-aminobutyric acid (GABA)-mediated changes within this region.
METHODS Standard protocol approvals, registrations, and patient consents. The study was approved by the joint ethics committee of the National Hospital for Neurology and Neurosurgery and University College London Institute of Neurology, London, UK. Subjects gave informed, written consent.
Patients. Sixty-three patients with focal epilepsy underwent EEG-fMRI, after which IEDs were correlated with the fMRI data in an event-related fashion. 11 Because IEDs occur spontaneously and unpredictably, the number of events captured varied widely across patients. To ensure the validity of the group analysis described below, i.e., to avoid any violation of homoscedasticity implicit in the loss of balance at the first level, it was mandatory only to include patients with a similar number of IEDs during fMRI data acquisition. 12, 13 Consequently, of the 63 patients with focal epilepsy, those with a spiking rate in the midrange level of activity in the group (between 1 and 20 IEDs/min) were selected, giving 19 patients (10 female; mean age 38 years, range 25-67 years) for the group analysis (for patient demographics, see table e-1a on the Neurology ® Web site at www.neurology.org).
A different patient group was studied with [ 11 C]FMZ PET: 18 patients (7 female; mean age 27 years, range 18 -47 years) with MRI reported as normal by an experienced neuroradiologist were recruited (table e-1b). All of these subjects had focal or secondarily generalized seizures. Patients were excluded from the study if they were taking benzodiazepines. A group of 24 healthy subjects (3 female) of similar age (mean age 31 years, range 20 -51 years), who had no evidence of a neurologic disorder and were taking no medication, were studied. Consumption of alcohol was not allowed during 48 hours preceding the scan. Written informed consent was obtained from all subjects, and approvals from local ethical committees and the UK Administration of Radioactive Substances Advisory Committee were obtained.
EEG and fMRI acquisition. Methods and results pertaining
to single-subject analyses have been reported elsewhere. 13 In summary, using magnetic resonance-compatible equipment, 10 EEG channels were recorded using the International 10 -20 System and bipolar EKGs. Over 35 minutes, 704 T2*-weighted single-shot gradient-echo echoplanar images (echo time ϭ 40, repetition time ϭ 3,000, 21 slices, voxel size 3.75 ϫ 3.75 ϫ 5 mm 3 ) were acquired continuously on a 1.5-T Horizon EchoSpeed MRI scanner (General Electric, Milwaukee, WI).
Patients were asked to rest with their eyes shut and to keep their head still. After removal of artifact on the in-scanner EEG, IEDs were marked by 2 trained observers. fMRI data were preprocessed and analyzed using statistical parametric mapping (SPM). 14 After the first 4 image volumes were discarded, the echoplanar image time series was realigned and normalized (Montreal Neurological Institute [MNI] template brain), and images were spatially smoothed with a cubic Gaussian kernel of 8 mm full-width at half-maximum. The 3 datasets of patients in whom the presumed electroclinical location of the epileptic focus was right-sided were flipped along the x-axis before normalization.
Spike-correlated EEG-fMRI group analysis. Onsets of
IEDs were used to build a linear model of effects of interest by convolution with a canonical hemodynamic response function (event-related design) and its temporal derivative to account for variations in the blood oxygen level-dependent (BOLD) response delay. Motion realignment parameters were modeled as a confound. 15 A single T-contrast image was generated per subject from the first (single-subject) level, and the images were used in a second-level analysis, to test for any common patterns across the group of patients. A random-effects model was used to identify any typical responses consistent across patients. 16 We used this approach to test the hypothesis of activation in the region of the presumed area tempestas. Bilateral 0.7 ϫ 1.4 ϫ 1.4 cm search volumes (totaling 2,744 mm 3 ) were each centered between the tip of the temporal pole and the orbitofrontal gyrus based on the aneurysm case report of Mizobuchi et al., 17 and, in these regions, fMRI signal changes were considered significant at p Ͻ 0.05 (family-wise error-corrected for multiple comparisons within the search volume). In addition, positive responses were explored across the whole brain at a significance threshold of p Ͻ 0.001 (uncorrected at the voxel level) to assess the presence of unspecific effects, e.g., subthreshold bilateral, or covering the entire region of interest or even beyond.
PET acquisition. The method has been described in detail previously. 18 In brief, scans were performed using an ECAT-953B PET scanner (CTI/Siemens, Knoxville, TN) in 3-dimensional mode, with the septa retracted to improve sensitivity. Scatter correction and attenuation correction were used in reconstruction to produce images with a resolution of 4.8 ϫ 4.8 ϫ 5.2 mm. Images containing 31 contiguous slices were produced with voxel dimensions of 2.09 ϫ 2.09 ϫ 3.43 mm. High specific activity [ 11 C]FMZ tracer was injected IV. A dynamic image sequence of 20 frames was acquired over 90 minutes.
FMZ PET data analysis. The derivation of an arterial plasma input function was performed as described previously. 19 Voxelby-voxel parametric images of FMZ volume of distribution (FMZ-V T ) were produced using spectral analysis. 20 For group analysis, 8 datasets were flipped about the anteroposterior axis to ensure that the epileptogenic focus was on the same (left) side in all patients. SPM was used for spatial transformations and statistical analysis. First, all images were transformed into a standard space. An in-house created FMZ-V T template that occupies the standard stereotaxic space defined by the MNI/International Consortium for Brain Mapping (ICBM) 152 templates as supplied with SPM was right-left reversed (flipped), rigid-body coregistered onto itself, and averaged using a soft mean, thus creating a symmetric template approximating MNI/ICBM 152 space. Second, the images were smoothed using a (10 ϫ 10 ϫ 6 mm full-width at half-maximum) Gaussian kernel to reduce high spatial frequency noise. Third, effects were estimated according to the general linear model at every voxel. Global activity was included as a confounding covariate. Patients and normal subjects were compared using a voxel-wise t test. To test hypotheses about regionally specific effects, the estimates were compared using linear contrasts. The resulting set of voxel values for each contrast constituted a statistical parametric map of the t statistic (SPM{t}). For the comparison of the patient and normal groups, the SPM{t} was transformed to the unit normal distribution (SPM{Z}), and, because we had no a priori hypotheses with regard to the regions to be examined, an uncorrected threshold of p Ͻ 0.01 was subjected to a correction for multiple nonindependent comparisons in terms of peak height (), taking into account the shape of the thresholded volume (spatial extent [] at p Ͻ 0.05), to allow the entire brain volume to be interrogated. 14 For the analysis of correlation between FMZ-V T and seizure frequency, the total number of seizures that occurred during the month before the PET scan (as determined from patients' prospectively compiled diaries) was included in the model in a voxel-wise linear regression. Effects were significant at p Ͻ 0.05 corrected for multiple comparisons using both and across the whole brain. 14 RESULTS EEG-fMRI. We identified 19 patients who had well-defined focal epilepsy syndromes (table e-1a). We found a p Ͻ 0.05 (corrected for multiple comparisons) correlation between IED occurrence and BOLD increase common to all 19 patients (i.e., typical for the group studied with 1-20 IED/min) in an area near the frontal piriform cortex (X, Y, Z ϭ Ϫ30, 6, Ϫ2, coordinates in Talairach space), on the same side as the presumed cortical epileptic focus (figure 1, table e-2). These increases were apparent on a single-subject level in 13 of 18 patients. No regions of decreased FMZ-V T were found. For comparison with the fMRI data, we analyzed the data to look for regions in which FMZ-V T correlated significantly with seizure frequency, confining our attention only to those regions identified in the first analysis. The lower the FMZ-V T in the same area near the frontal piriform cortex, the higher was the seizure frequency over the preceding month (z ϭ 3.97) ( figure 3 ). This correlation remained significant, even when the subject with very frequent seizures (Ͼ70/month) was removed. There were no significant correlations between increasing FMZ-V T and seizure frequency.
DISCUSSION
Our study is unique for the following 2 reasons. 1) By averaging the imaging data across a group of patients with different sites of seizure onset, we were able to eliminate signal changes associated with sites of seizure onset (which varied across the patients) and selectively detect signal changes common to all patients. 2) In 2 independent datasets using 2 different imaging modalities, we identified an area in the human piriform (primary olfactory) cortex that was active in association with interictal EEG spikes and where benzodiazepine-GABA A receptor complex expression was reduced as seizure frequency increased ( figure 4 ). This region is located in close proximity to the physiologically defined deep piriform cortex (area tempestas) from which convulsants are known to initiate temporal lobe seizures, 20,21 and blockade of glutamate 4,20 -22 or application of a GABA agonist in this area 22 reduces limbic motor seizures in rodents and nonhuman primates. 1 The piriform/primary olfactory cortex, because of its unique intrinsic associative fiber system and its various connections to and from other limbic nuclei, 23-25 might be part of an epileptic network that is pivotal in the genesis of focal seizures, facilitating and intensifying the spread of seizures from a focus in the hippocampus or other limbic sites to cortical and subcortical regions along pathways that are also used in normal movements. 26 -29 The deep piriform cortex is a site at which unilateral microinjection of a GABA receptor antagonist or glutamate receptor agonists triggered limbic motor seizures in rats and nonhuman primates, whereas enhancement of GABA-mediated mechanisms reduced seizure activity. Before our study, there was no direct evidence implicating the piriform cortex in the pathogenesis of human epilepsy. Our observed association of low FMZ-V T in the human frontal piriform (primary olfactory) cortex with increased seizure frequency is concordant with findings in animal models of focal epilepsies. 30, 31 FMZ-V T is directly correlated with central benzodiazepine receptor density (B max ) and hence may act as an index of GABA A density. Postsynaptic increases in the number of GABA A receptors underlying the inhibitory potentiation in the kindling model have been described. 32 Such an increase in available binding sites (B max ) will lead to an increase in FMZ-V T . Likewise, a recent study using the pilocarpine model found presynaptic and postsynaptic changes of GABA transmission involving changes of GABA A receptor subunit composition. 33 Thus, increased density or affinity of available receptors per neuron, either on abnormal nerve cells or as an adaptive response to the abnormal neuronal activity, may explain the observed increases of FMZ binding. If increased FMZ-receptor binding reflects increased GABAergic inhibition locally, the increased inhibition in this area would result in reduced cortical excitability in the lobe of seizure origin. Thus, we can speculate that the greater the increase in FMZ binding the fewer the seizures, as observed in this study. Likewise, greater reductions of FMZ binding were found as the interval since the last seizure got shorter. 34 This potential plasticity of receptors after seizures is consistent with our observation of greater reductions of FMZ binding as the seizure frequency got higher. This observation holds true in particular for patients with frequent seizures (Ͼ10/month) (figure 4) but not necessarily for patients with very few seizures, in whom PET scans were performed at various intervals since the last seizure. For group comparisons, the images of patients with clear right-sided focus were right-left reversed before normalization, making the focus appear on the same side in all patients. We have previously carefully investigated the influence of such right-left reversals before spatial normalization, and we did not find a difference in the statistical results. 35 In both fMRI and PET groups, few patients had bilateral or no localizing features on MRI, EEG, or seizure semiology, but wrong lateralization would only reduce the likelihood of observing a unilateral (ipsilateral) effect.
Our findings from combined hemodynamic and neuroreceptor imaging studies support the concept of a network of cortical and subcortical structures modulating epileptiform activity. Our group analysis will be less sensitive to IED-correlated BOLD signal changes, reflecting potentially different irritative and seizure-onset zones, but will highlight common features (typical effects) in a group of patients. Despite exhibiting disparate sites of seizure foci, the patients in our study shared a common region of dischargecorrelated activity. We restricted our analyses to EEG-fMRI studies with 1-20 IED/min. This enabled us to make valid inferences at the group level using a 2-stage procedure but limited the group size to 19 patients. 36 Violations of homoscedasticity implicit in the loss of balance at the first level can make the second-level inference less efficient but would not bias or invalidate it. 37 At the single-subject level, there may be other areas fulfilling such a role, which failed to reach significance as a result of group averaging. Interestingly, recent PET studies have suggested that increased FMZ binding in one of these areas, the retroventricular area (table e- 2) , is predictive of poor surgical outcome. 38 Although there is likely to be considerable individual variability in potential epileptogenic networks, some areas are common to all networks and may be potential target areas for new therapeutic approaches. Our findings support an understanding of epilepsy moving on from the traditional zone concept to that of a network theory. 39, 40 
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